ATE139847T1 - Verfahren zum nachweis der erythrozytenagglutination zur feststellung der blutverträglichkeit - Google Patents

Verfahren zum nachweis der erythrozytenagglutination zur feststellung der blutverträglichkeit

Info

Publication number
ATE139847T1
ATE139847T1 AT91400722T AT91400722T ATE139847T1 AT E139847 T1 ATE139847 T1 AT E139847T1 AT 91400722 T AT91400722 T AT 91400722T AT 91400722 T AT91400722 T AT 91400722T AT E139847 T1 ATE139847 T1 AT E139847T1
Authority
AT
Austria
Prior art keywords
blood compatibility
determine blood
erythrocyte agglutination
detecting erythrocyte
detecting
Prior art date
Application number
AT91400722T
Other languages
English (en)
Inventor
Lucienne Nee Wartel Mannessier
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9395144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE139847(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Application granted granted Critical
Publication of ATE139847T1 publication Critical patent/ATE139847T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91400722T 1990-03-27 1991-03-18 Verfahren zum nachweis der erythrozytenagglutination zur feststellung der blutverträglichkeit ATE139847T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9003873A FR2660437B1 (fr) 1990-03-27 1990-03-27 Procede de mise en evidence d'agglutination erythrocytaire destine aux analyses de comptabilites sanguines.

Publications (1)

Publication Number Publication Date
ATE139847T1 true ATE139847T1 (de) 1996-07-15

Family

ID=9395144

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91400722T ATE139847T1 (de) 1990-03-27 1991-03-18 Verfahren zum nachweis der erythrozytenagglutination zur feststellung der blutverträglichkeit

Country Status (9)

Country Link
EP (1) EP0454509B1 (de)
AT (1) ATE139847T1 (de)
DE (1) DE69120463T2 (de)
DK (1) DK0454509T3 (de)
ES (1) ES2089160T3 (de)
FR (1) FR2660437B1 (de)
GR (1) GR3020960T3 (de)
PT (1) PT97151B (de)
SG (1) SG47462A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055095C (en) * 1990-11-09 2003-05-13 Johnna B. Hawk Column agglutination assay and device
FR2697633B1 (fr) * 1992-10-21 1995-01-20 Pasteur Sanofi Diagnostics Procédé d'immunodiagnostic en matrice poreuse avec particules sensibilisées et dispositif pour sa mise en Óoeuvre.
US5552064A (en) * 1993-02-26 1996-09-03 Ortho Diagnostic Systems, Inc. Column agglutination assay and device using biphasic centrifugation
FR2719122B1 (fr) * 1994-04-22 1996-07-12 Scibiex Sarl Dispositif et procédé d'analyse immunologique.
NL9400777A (nl) * 1994-05-10 1995-12-01 Stichting Centraal Lab Vaste-fase filtratiemethode voor antigeen- en antistofbepalingen in de bloedgroepserologie, en testkit.
US5905028A (en) * 1994-05-17 1999-05-18 Gamma Biologicals, Inc. Method and apparatus useful for detecting bloodgroup antigens and antibodies
FR2732037B1 (fr) * 1995-03-20 1997-05-30 Dbv Procede de detection de microorganismes par separation et culture sur un systeme gelifie, systeme gelifie et necessaire de dosage pour mettre en oeuvre ce procede, utilisation en microbiologie
EP0805354A1 (de) * 1996-04-29 1997-11-05 Matthew R. Dr. Pincus Direkter Nachweis von unerwarteten Alloantikörper in Seren von prospectiven Transfusionsempfängern unter Verwendung eines neuen Hämoglutinationstestes
NL1003570C2 (nl) * 1996-07-11 1998-01-15 Stichting Centraal Lab Methode voor antigeen- en antistofbepaling in de bloedgroepserologie.
ES2126521B1 (es) * 1997-06-05 1999-11-16 Transfusion De La Comunidad Va Metodo para la deteccion de antigenos presentes en la membrana de hematies, propios o acoplados y de anticuerpos irregulares en muestras de suero.
US20070100557A1 (en) * 2005-10-24 2007-05-03 Yi Zhang Selection of genotyped transfusion donors by cross-matching to genotyped recipients
EP1840572A1 (de) * 2006-03-30 2007-10-03 Stiftung Für Diagnostische Forschung System für den verbesserten Nachweis von Antikörpern gegen Erythrozytenantigene

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039195B1 (de) * 1980-04-28 1986-06-18 Montefiore Hospital and Medical Center Verfahren zur Feststellung von Antikörpern
GB2117514B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Polyvalent antiglobulin reagent
FR2577321B1 (fr) * 1985-02-08 1989-04-28 Lapierre Yves Dispositif et procede de mise en evidence d'agglutinats erythrocytaires
JPH087215B2 (ja) * 1987-08-24 1996-01-29 シュティフツング・フュア・ディアグノスティッシュ・フォルシュンク 抗原および／又は抗体の検出方法および検出用の試験キット

Also Published As

Publication number Publication date
EP0454509B1 (de) 1996-06-26
PT97151B (pt) 1999-12-31
FR2660437B1 (fr) 1993-11-19
GR3020960T3 (en) 1996-12-31
FR2660437A1 (fr) 1991-10-04
PT97151A (pt) 1991-11-29
EP0454509A2 (de) 1991-10-30
DK0454509T3 (da) 1996-11-04
DE69120463D1 (de) 1996-08-01
SG47462A1 (en) 1998-04-17
DE69120463T2 (de) 1997-01-23
ES2089160T3 (es) 1996-10-01
EP0454509A3 (de) 1991-11-06

Similar Documents

Publication Publication Date Title
ATE139847T1 (de) Verfahren zum nachweis der erythrozytenagglutination zur feststellung der blutverträglichkeit
Tovey et al. Standardization of allergens: qualitative definition of house dust mite extracts following electroblotting and detection of components with antibody and lectin probes
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
ATE75041T1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zellleukozytenantik¯rpern.
CA1195925A (en) Method for assaying antigen-antibody reactions and reagent therefor
US3912805A (en) Reagent and assay for human fibrinogen degradation products
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
FI895366A0 (fi) Vesipitoinen suspensio diagnostisia kokeita varten ja menetelmä sen valmistamiseksi sekä diagnostisia menetelmiä ja niissä käytettäviä reagensseja ja testipakkauksia
DK0462115T3 (da) Diagnostisk proteinmarkør for blærecancer
DE3780446D1 (de) Verfahren zur feststellung von schwangerschaftsstoerungen.
EP0762121B1 (de) Antigen für Enzymimmuntest und Verfahren zur Messung von erythrozytären Antikörpern
ATE60445T1 (de) Verfahren und testelement zum auffinden von zellaesionen.
Prause Immunoelectrophoretic determination of tear fluid proteins collected by the Schirmer I test
Maidment Jr et al. Isoelectric focusing analysis of soluble immune complexes bound to Protein A-Sepharose
CA1049405A (en) Test method to determine pulmonary embolism
Williams et al. Reactions of Antibodies with Soluble Antigens: Methods in Immunology and Immunochemistry, Vol. 3
Mischler et al. Immunological identification of human seminal stains
Coonrod et al. Immunoelectrophoresis for detection of polysaccharides in immune complexes
Strony et al. Demonstration of cerebrospinal fluid oligoclonal banding in neurologic diseases by agarose gel electrophoresis and immunofixation
WO1998039656A1 (en) Method for detecting the presence of an immunologically reactive molecule in a sample
SU1175442A1 (ru) Способ диагностики гипоксии мозга у новорожденных
Shapshak et al. Concentration of cerebrospinal fluid does not affect immunoglobulin G oligoclonal banding patterns
JP2704760B2 (ja) 凝集抗体
Plan et al. Comparison between agarose gel electrophoresis (Panagel) of cerebrospinal fluid with silver staining, and polyacrylamide disc gel electrophoresis for demonstration of the oligoclonal pattern in neurological disorders
KR890007077A (ko) Atlv항체의 측정시약 및 측정방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time